| Dr Diana Egle Lindner, MD | |
|
14350 Se Eastgate Way, Bellevue, WA 98007 | |
| (206) 296-9724 | |
| Not Available |
| Full Name | Dr Diana Egle Lindner |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 14350 Se Eastgate Way, Bellevue, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306911151 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 12362 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Diana Egle Lindner, MD 7240 86 Ave. Se, Mercer Island, WA 98040 Ph: (206) 232-2580 | Dr Diana Egle Lindner, MD 14350 Se Eastgate Way, Bellevue, WA 98007 Ph: (206) 296-9724 |
News Archive
Children with autism may have lower quality handwriting and trouble forming letters compared to children without autism, according to a study published in the November 10, 2009, print issue of Neurology®, the medical journal of the American Academy of Neurology.
Combining electroencephalogram (EEG) data with clinical observations can help doctors to better determine whether generalized epilepsy patients will respond to treatment, according to a study led by Rutgers researchers.
The Swedish company Laccure AB has developed a breakthrough women's health product that is effective, safe and user-friendly. Laccure's owners are now aiming to divest the company to a buyer with appropriate resources to launch the product.
Alvine Pharmaceuticals, Inc. today announced the presentation of data from a Phase 2A trial of its lead compound, ALV003, at the 2012 Digestive Diseases Week (DDW) meeting held in San Diego, California. The study results met the primary endpoint of demonstrating that oral ALV003, administered in the context of a gluten free diet (GFD), can diminish gluten-induced intestinal mucosal injury in well-controlled celiac disease patients. The company plans to initiate a Phase 2B trial later this year.
Patients with pulmonary arterial hypertension (PAH) receiving combination therapy with intravenous (IV) PGI2 may suffer from greater disease burden compared with those receiving monotherapy or combination therapy, excluding IV PGI2.
› Verified 9 days ago
Eric Albert Gustafson, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2700 Northup Way, Bellevue, WA 98004 Phone: 425-827-4600 | |
Dr. Arlene Elizabeth Ritzen, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1900 116th Ave Ne, Bellevue, WA 98004 Phone: 425-453-0404 | |
Dr. Emily Susan Showman, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3633 136th Place Se, Suite #110, Bellevue, WA 98006 Phone: 425-747-7202 Fax: 425-643-0635 | |
Ildiko Hegyvary Thomas, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000 | |
Bill M Fournarakis, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2700 Northup Way, Bellevue, WA 98004 Phone: 425-827-4600 Fax: 425-828-2256 | |
Irene Hwang, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3633 136th Place Se, Suite #110, Bellevue, WA 98006 Phone: 425-747-7202 Fax: 425-643-0635 | |
Pamela Laborde, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3633 136th Place Se, Suite #110, Bellevue, WA 98006 Phone: 425-747-7202 Fax: 425-643-0635 |